XOMA Royalty (XOMA) Cash & Equivalents Growth (1y) (2011 - 2026)
XOMA Royalty (XOMA) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
988.88% |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-68.22% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
0.00% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
4.77% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
3.35% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
269.98% |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
17.50% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
XOMA Royalty |
5.48 Mn |
-60.60 Mn |
- |
1,367.76% |
| Date | Value |
|---|
| Mar 31, 2026 |
1,367.76% |
| Dec 31, 2025 |
822.94% |
| Sep 30, 2025 |
153.41% |
| Jun 30, 2025 |
-95.14% |
| Mar 31, 2025 |
-95.72% |
| Dec 31, 2024 |
-94.14% |
| Sep 30, 2024 |
-88.00% |
| Jun 30, 2024 |
358.29% |
| Mar 31, 2024 |
207.51% |
| Dec 31, 2023 |
405.91% |
| Sep 30, 2023 |
10.83% |
| Jun 30, 2023 |
-62.25% |
| Mar 31, 2023 |
-49.54% |
| Dec 31, 2022 |
-67.53% |
| Sep 30, 2022 |
-56.08% |
| Jun 30, 2022 |
5.37% |
| Mar 31, 2022 |
29.48% |
| Dec 31, 2021 |
10.81% |
| Sep 30, 2021 |
50.37% |
| Jun 30, 2021 |
59.51% |
